98%
921
2 minutes
20
Ethnopharmacological Relevance: Panax ginseng C.A. Meyer (ginseng), a traditional Chinese medicine, is famous for "Qi-tonifying" effect and widely used for healthcare and therapeutic effects in China. Modern pharmacology showed that Ginseng had a potential impact on hematopoietic stem cells (HSCs) that promote the regeneration of all blood cells in the bone marrow. The "Qi-tonifying" effect of ginseng might have close correlation with hematopoietic function. However, the protective effect of ginseng on HSCs has been rarely studied.
Aim Of The Study: To elucidate the difference of chemical composition and the effects of ginseng extract (GE), total ginsenosides (TG) and total polysaccharides (TP) on HSCs of cyclophosphamide (CYP)-induced mice.
Materials And Methods: The ginsenosides, monosaccharide and molecular distribution of GE, TG, and TP were detected. We established the mouse myelosuppression model induced by CYP. Eight ginsenosides in mice plasma were detected with high-performance liquid chromatography-mass spectrometer (MS)/MS in GE and TG group. Blood cell parameters (red blood cell, hemoglobin, reticulocyte, platelet, white blood cell, neutrophil, and lymphocyte) of plasma, oxidative stress indicators (superoxide dismutase, catalase, glutathione peroxidase, lactate dehydrogenase, malondialdehyde, and myeloperoxidase) of liver, cell differentiation marker (CD33, and GR-1) and colony forming of HSCs were detected. Ribonucleic acid (RNA)-sequencing analysis was performed on purified HSCs to find differentially expressed genes (DEGs). And the expression of DEGs was verified by quantitative polymerase chain reaction (qPCR), western blot, and immunohistochemical (IHC).
Results: Our results showed that 24 and 34 ginsenosides were detected in the GE and TG, and the total sugar content was 72.28 %, 4.68 %, and 89.79 % in GE, TG and TP, respectively. The weight-average molar mass/number-average molar mass (Mw/Mn) values of GE and TP were 2.96 and 1.23. TP showed homogeneous polysaccharide. The results of animal experiments showed that Rb1, Rc, Rb2, Rb3, and Rd of mouse serum in TG group was 22.91, 11.64, 10.73, 9.36, and 8.61 times in GE group, respectively. GE, TG and TP obviously elevated the numbers of blood cells, and improved oxidative stress indicator of liver. The results of RNA-sequencing analysis showed that DEGs in GE, TG and TP groups were primarily focused on signaling pathways related to HSCs. GE and TG obviously promoted the expression of Notch1, Notch2 and Jag1, and inhibited the expression of Hes1 of HSCs in model mice via activating Notch signal pathway. Meanwhile, GE and TG also obviously promoted the expression of Wnt7b, Wnt10b, and Fzd6 of HSCs by activating Wnt signal pathway. However, TP hardly activated the expression of these genes in Notch and Wnt signal pathways. Moreover, TG significantly increased the expression of CD33, CD38, CD14, CD4, CD19 and Gp1bα, and GE remarkably increased the expressions of CD34, CD14, CD4, and Gp1bα. GE and TG significantly increased the Gr-1 and decreased the Gr-1. However, TP played less role in HSCs.
Conclusions: This study found that TG and GE showed a strong protection on HSCs in model mice induced by CYP via activating the Notch and Wnt signal pathways, however, TP could not activate HSCs. Therefore, we think that ginsenosides from GE and TG are important chemical components in protecting the function of HSCs by activating the Notch and Wnt signal pathways.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jep.2025.119798 | DOI Listing |
Adv Sci (Weinh)
September 2025
China-New Zealand Joint Laboratory on Biomedicine and Health, State Key Laboratory of Immune Response and Immunotherapy, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, GIBH-HKU Guangdong-Hong Kong Stem Cell and Regenerative Medicine Research Centre, GIBH-CUHK Joint Resea
TP53 mutations are highly associated with hepatocellular carcinoma (HCC), a common and deadly cancer. However, few primary drivers in the progression of HCC with mutant TP53 have been identified. To uncover tumor suppressors in human HCC, a genome-wide CRISPR/Cas9-based screening of primary human hepatocytes with MYC and TP53 overexpression (MT-PHHs) is performed in xenografts.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Reproductive Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Snai2 is a transcription factor that inhibits the proliferation of cervical cancer cells and tumor growth. The expression of Snai2 inhibited the expression of β-catenin and impaired Wnt/β-catenin signaling pathway activity. The results of the RNA sequence in Snai2-overexpressing cervical cancer cells implied a strong correlation between Snai2 and TRIM31 with ubiquitin ligase activity.
View Article and Find Full Text PDFJBMR Plus
October 2025
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, 6009, Australia.
Genome-wide association studies (GWAS) relevant to osteoporosis have identified hundreds of loci; however, understanding how these variants influence the phenotype is complicated because most reside in non-coding DNA sequence that serves as transcriptional enhancers and repressors. To advance knowledge on these regulatory elements in osteoclasts (OCs), we performed Micro-C analysis, which informs on the genome topology of these cells and integrated the results with transcriptome and GWAS data to further define loci linked to BMD. Using blood cells isolated from 4 healthy participants aged 31-61 yr, we cultured OC in vitro and generated a Micro-C chromatin conformation capture dataset.
View Article and Find Full Text PDFCytotechnology
October 2025
Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 226001 China.
[This corrects the article DOI: 10.1007/s10616-025-00761-3.].
View Article and Find Full Text PDFOncol Res
September 2025
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León (UANL), Monterrey, 64460, Mexico.
Emerging evidence highlights the potential of bioactive compounds, particularly polyphenols, as adjunctive therapeutic agents in the treatment of pancreatic cancer (PC), one of the most aggressive malignancies. This review focuses on epigallocatechin gallate (EGCG) and resveratrol due to their extensively documented anticancer activity, favorable safety profiles, and their unique ability to modulate multiple signaling pathways relevant to pancreatic tumorigenesis. Among polyphenols, these two have shown superior anti-cancer activity, epigenetic regulatory effects, and synergy with standard chemotherapies in preclinical pancreatic cancer models.
View Article and Find Full Text PDF